These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 16729301

  • 1. Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus.
    Tripi LM, Manzi S, Chen Q, Kenney M, Shaw P, Kao A, Bontempo F, Kammerer C, Kamboh MI.
    Arthritis Rheum; 2006 Jun; 54(6):1928-39. PubMed ID: 16729301
    [Abstract] [Full Text] [Related]

  • 2. Genetic variation in the paraoxonase-3 (PON3) gene is associated with serum PON1 activity.
    Sanghera DK, Manzi S, Minster RL, Shaw P, Kao A, Bontempo F, Kamboh MI.
    Ann Hum Genet; 2008 Jan; 72(Pt 1):72-81. PubMed ID: 17900266
    [Abstract] [Full Text] [Related]

  • 3. Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.
    Kovács TJ, Harris S, Vas TK, Seres I, Short CD, Wittmann IK, Paragh G, Mackness MI, Mackness B, Durrington PN, Nagy JM, Brenchley PE.
    J Nephrol; 2006 Jan; 19(6):732-8. PubMed ID: 17173245
    [Abstract] [Full Text] [Related]

  • 4. Is paraoxonase 192 gene polymorphism a risk factor for membranoproliferative glomerulonephritis in children?
    Bilge I, Sirin A, Agachan B, Emre S, Sadikoglu B, Yilmaz H, Sucu A, Isbir T.
    Cell Biochem Funct; 2007 Jan; 25(2):159-65. PubMed ID: 16175651
    [Abstract] [Full Text] [Related]

  • 5. A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus.
    Svenungsson E, Gustafsson J, Leonard D, Sandling J, Gunnarsson I, Nordmark G, Jönsen A, Bengtsson AA, Sturfelt G, Rantapää-Dahlqvist S, Elvin K, Sundin U, Garnier S, Simard JF, Sigurdsson S, Padyukov L, Syvänen AC, Rönnblom L.
    Ann Rheum Dis; 2010 May; 69(5):834-40. PubMed ID: 19762360
    [Abstract] [Full Text] [Related]

  • 6. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
    Chi DS, Ling WH, Ma J, Xia M, Hou MJ, Wang Q, Zhu HL, Tang ZH, Yu XP.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
    [Abstract] [Full Text] [Related]

  • 7. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
    Can Demirdöğen B, Türkanoğlu A, Bek S, Sanisoğlu Y, Demirkaya S, Vural O, Arinç E, Adali O.
    Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
    [Abstract] [Full Text] [Related]

  • 8. Role of the Fcgamma receptor IIIA-V/F158 polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis.
    Li LH, Yuan H, Pan HF, Li WX, Li XP, Ye DQ.
    Scand J Rheumatol; 2010 Mar; 39(2):148-54. PubMed ID: 20059375
    [Abstract] [Full Text] [Related]

  • 9. Variation at the paraoxonase gene locus contributes to carotid arterial wall thickness in subjects with familial hypercholesterolemia.
    Roest M, Jansen AC, Barendrecht A, Leus FR, Kastelein JJ, Voorbij HA.
    Clin Biochem; 2005 Feb; 38(2):123-7. PubMed ID: 15642273
    [Abstract] [Full Text] [Related]

  • 10. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
    Kerkeni M, Addad F, Chauffert M, Chuniaud L, Miled A, Trivin F, Maaroufi K.
    Clin Biochem; 2006 Aug; 39(8):821-5. PubMed ID: 16875684
    [Abstract] [Full Text] [Related]

  • 11. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.
    Martens HA, Zuurman MW, de Lange AH, Nolte IM, van der Steege G, Navis GJ, Kallenberg CG, Seelen MA, Bijl M.
    Ann Rheum Dis; 2009 May; 68(5):715-20. PubMed ID: 18504288
    [Abstract] [Full Text] [Related]

  • 12. Human paraoxonase gene polymorphisms and coronary artery disease risk.
    Mendonça MI, Dos Reis RP, Freitas AI, Sousa AC, Pereira A, Faria P, Gomes S, Silva B, Santos N, Serrão M, Ornelas I, Freitas S, Araújo JJ, Brehm A, Cardoso AA.
    Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995
    [Abstract] [Full Text] [Related]

  • 13. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, Dong X, Chen W, Kim MH, Weng HH, Furst DE, Gorn A, McMahon M, Taylor M, Brahn E, Hahn BH, Tsao BP.
    Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
    [Abstract] [Full Text] [Related]

  • 14. Poly(ADP-ribose) polymerase (PARP) polymorphisms associated with nephritis and arthritis in systemic lupus erythematosus.
    Hur JW, Sung YK, Shin HD, Park BL, Cheong HS, Bae SC.
    Rheumatology (Oxford); 2006 Jun; 45(6):711-7. PubMed ID: 16461442
    [Abstract] [Full Text] [Related]

  • 15. Risk of carotid atherosclerosis is associated with low serum paraoxonase (PON1) activity among arsenic exposed residents in Southwestern Taiwan.
    Li WF, Sun CW, Cheng TJ, Chang KH, Chen CJ, Wang SL.
    Toxicol Appl Pharmacol; 2009 Apr 15; 236(2):246-53. PubMed ID: 19371607
    [Abstract] [Full Text] [Related]

  • 16. Relationship between human paraoxonase-1 activity and PON1 polymorphisms in Mexican workers exposed to organophosphate pesticides.
    López-Flores I, Lacasaña M, Blanco-Muñoz J, Aguilar-Garduño C, Sanchez-Villegas P, Pérez-Méndez OA, Gamboa-Avila R.
    Toxicol Lett; 2009 Jul 24; 188(2):84-90. PubMed ID: 19446239
    [Abstract] [Full Text] [Related]

  • 17. Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus.
    Dasgupta S, Demirci FY, Dressen AS, Kao AH, Rhew EY, Ramsey-Goldman R, Manzi S, Kammerer CM, Kamboh MI.
    BMC Med Genet; 2011 Jan 11; 12():7. PubMed ID: 21223581
    [Abstract] [Full Text] [Related]

  • 18. Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus.
    Velázquez-Cruz R, Orozco L, Espinosa-Rosales F, Carreño-Manjarrez R, Solís-Vallejo E, López-Lara ND, Ruiz-López IK, Rodríguez-Lozano AL, Estrada-Gil JK, Jiménez-Sánchez G, Baca V.
    Eur J Hum Genet; 2007 Mar 11; 15(3):336-41. PubMed ID: 17228327
    [Abstract] [Full Text] [Related]

  • 19. Association between paraoxonase-1 gene Q192R and L55M polymorphisms in systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS) in a population from Cairo of Egypt.
    Ibrahim AA, El-Lebedy D, Ashmawy I, Hady MA.
    Clin Rheumatol; 2017 Jun 11; 36(6):1305-1310. PubMed ID: 28185016
    [Abstract] [Full Text] [Related]

  • 20. Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease.
    Jarvik GP, Hatsukami TS, Carlson C, Richter RJ, Jampsa R, Brophy VH, Margolin S, Rieder M, Nickerson D, Schellenberg GD, Heagerty PJ, Furlong CE.
    Arterioscler Thromb Vasc Biol; 2003 Aug 01; 23(8):1465-71. PubMed ID: 12805074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.